Role of nutrition in HIV infection: Review of evidence for more effective programming in resource-limited settings

Food and Nutrition Bulletin

Volumn 31, Issue 4, 2010, Pages

  De Pee, Saskia ^a,b   Semba, Richard D ^c  

^a World Food Programme   (Italy)

^b TUFTS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Food insecurity; HIV infection; Malnutrition; Micronutrients; Resource limited settings; Weight loss

Indexed keywords

BODY MASS; DIET; FOOD SECURITY; FOOD SUPPLEMENTATION; HEALTH RISK; HEALTH SERVICES; HORMONE; HUMAN IMMUNODEFICIENCY VIRUS; LITERATURE REVIEW; MALNUTRITION; MORTALITY; MUSCLE; NUTRIENT LIMITATION; TRACE ELEMENT; WORLD HEALTH ORGANIZATION;

ANTIRETROVIRUS AGENT; TRACE ELEMENT;

ADULT; BODY MASS; CATERING SERVICE; COMPLICATION; DEFICIENCY; DIETARY SUPPLEMENT; FORTIFIED FOOD; HEALTH CARE POLICY; HIV INFECTIONS; HUMAN; MALNUTRITION; NUTRITIONAL STATUS; WEIGHT GAIN; WEIGHT REDUCTION; WORLD HEALTH ORGANIZATION;

ADULT; ANTI-RETROVIRAL AGENTS; BODY MASS INDEX; DIETARY SUPPLEMENTS; FOOD SUPPLY; FOOD, FORTIFIED; HIV INFECTIONS; HUMANS; MALNUTRITION; MICRONUTRIENTS; NUTRITION POLICY; NUTRITIONAL STATUS; WEIGHT GAIN; WEIGHT LOSS; WORLD HEALTH ORGANIZATION;

EID: 78751655708     PISSN: 03795721     EISSN: None     Source Type: Journal    
DOI: 10.1177/15648265100314s403     Document Type: Article

References (212)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS). 2008 Report on the global AIDS/HIV epidemic. Geneva: UNAIDS, 2008.
2. Quinn TC. HIV epidemiology and the effects of antiviral therapy on long-term consequences. AIDS 2008; 22(suppl 3): S7-12.
3. Sztam KA, Fawzi WW, Duggan C. Macronutrient supplementation and food prices in HIV treatment. J Nutr 2010; 140: 213-23.
4. Victora CG, Adair L, Fall C, Hallal P, Martorell R, Richter L, Sachdev HS. Maternal and child undernutrition: consequences for adult health and human capital. Lancet 2008; 371: 340-57.
5. Semba RD, Tang AM. Micronutrients and the pathogenesis of human immunodeficiency virus infection. Br J Nutr 1999; 81: 181-9.
6. Semba RD, Darnton-Hill I, de Pee S. Addressing tuberculosis in the context of malnutrition and HIV coinfection. Food Nutr Bull 2010; 31(Suppl): S345-S364.
7. Frega R, Duffy F, Rawat R, Grede N. Food insecurity in the context of HIV/AIDS: a framework for a new era of programming. Food Nutr Bull 2010; 31 (Suppl): S292-S312.
8. Semba RD. Nutrition and development: a historical perspective. In: Semba RD, Bloem MW, eds. Nutrition and health in developing countries, 2nd ed. Totowa, NJ, USA: Humana Press, 2008: 1-31.
9. Schroeder DG. Malnutrition. In: Semba RD, Bloem MW, eds. Nutrition and health in developing countries, 2nd ed. Totowa, NJ, USA: Humana Press, 2008: 341-76.
10. Abrams B, Duncan D, Hertz-Picciotto I. A prospective study of dietary intake and acquired immune deficiency syndrome in HIV-seropositive homosexual men. J Acquir Immune Defic Syndr 1993; 6: 949-58.
11. Tang AM, Graham NMH, Kirby AJ, McCall AD, WUlett WC, Saah AJ. Dietary micronutrient intake and risk progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men. Am J Epidemiol 1993; 138: 1-15.
12. Baum M, Cassetti L, Bonvehi P, Shor-Posner G, Lu Y, Sauberlich H. Inadequate dietary intake and altered nutritional status in early HIV-1 infection. Nutrition 1994; 10: 16-20.
13. Luder E, Godfrey E, Godbold J, Simpson DM. Assessment of nutritional, clinical, and immunologic status of HIV-infected, inner-city patients with multiple risk factors. J Am Diet Assoc 1995; 95: 655-60.
14. Smit E, Graham NMH, Tang A, Flynn C, Solomon L, Vlahov D. Dietary intake of community-based HIV-1 seropositive and seronegative injecting drug users. Nutrition 1996; 12: 496-501.
15. Kim JH, Spiegelman D, Rimm E, Gorbach SL. The correlates of dietary intake among HIV-positive adults. Am J Clin Nutr 2001; 74: 852-61.
16. Woods MN, Spiegelman D, Knox TA, Forrester JE, Connors JL, Skinner SC, Suva M, Kim JH, Gorbach SL. Nutrient intake and body weight in a large HIV cohort that includes women and minorities. J Am Diet Assoc 2002; 102: 203-11.
17. Wig N, Bhatt SP, Sakhuja A, Srivastava S, Agarwal S. Dietary adequacy in Asian Indians with HIV. AIDS Care 2008; 20: 370-5.
18. Food and Nutrition Board, Institute of Medicine. Dietary reference intakes. Applications in dietary assessment. Washington, DC: National Academy Press, 2000.
19. Baum MK, Shor-Posner G, Bonvehi P, Cassetti I, Lu Y, Mantero-Atienza E, Beach RS, Sauberlich HE. Influence of HIV-infection on vitamin status and requirements. Ann N Y Acad Sci 1992; 669: 165-73.
20. Beach RS, Mantero-Atienza E, Shor-Posner G, Javier JJ, Szapocznik J, Morgan R, Sauberlich HE, Cornwell PE, Eisdorfer C, Baum MK. Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS 1992; 6: 701-8.
21. Tang AM, Graham NM, Semba RD, Saah AJ. Association between serum vitamin A and E levels and HIV-1 disease progression. AIDS 1997; 11: 613-20.
22. Semba RD, Graham NM, Caiaffa WT, Margolick JB, Clement L, Vlahov D. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch Intern Med 1993; 153: 2149-54.
23. Semba RD, Caiaffa WT, Graham NM, Cohn S, Vlahov D. Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users. J Infect Dis 1995; 171: 1196-202.
24. Kassu A, Andualem B, Van Nhien N, Nakamori M, Nishikawa T, Yamamoto S, Ota F. Vitamin A deficiency in patients with diarrhea and HIV infection in Ethiopia. Asia Pac J Clin Nutr 2007; 16(suppl 1): 323-8.
25. Semba RD, Miotti PG, Chiphangwi JD, Saah AJ, Canner JK, Dallabetta GA, Hoover DR. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 1994; 343: 1593-7.
26. Semba RD, Kumwenda N, Taha TE, Mtimavalye L, Broadhead R, Miotti PG, Eisinger W, Hoover D, Chiphangwi JD. Plasma and breast milk vitamin A as indicators of vitamin A status in pregnant women. Int J Vitam Nutr Res 2000; 70: 271-7.
27. Friis H, Gomo E, Koestel P, Ndhlovu P, Nyazema N, Krarup H, Michaelsen KF. HIV and other predictors of serum beta-carotene and retinol in pregnancy: a cross-sectional study in Zimbabwe. Am J Clin Nutr 2001; 73: 1058-65.
28. Phuapradit W, Chaturachinda K, Taneepanichskul S, Sirivarasry J, Khupulsup K, Lerdvuthisopon N. Serum vitamin A and beta-carotene levels in pregnant women infected with human immunodeficiency virus-1. Obstet Gynecol 1996; 87: 564-7.
29. Dancheck B, Nussenblatt V, Ricks MO, Kumwenda N, Neville MC, Moncrief DT, Taha TE, Semba RD. Breast milk retinol concentrations are not associated with systemic inflammation among breast-feeding women in Malawi. J Nutr 2005; 135: 223-6.
30. Melikian G, Mmiro F, Ndugwa C, Perry R, Jackson JB, Garrett E, Tielsch J, Semba RD. Relation of vitamin A and carotenoid status to growth failure and mortality among Ugandan infants with human immunodeficiency virus. Nutrition 2001; 17: 567-72.
31. Bogden JD, Baker H, Frank O, Perez G, Kemp F, Bruening K, Louria D. Micronutrient status and human immunodeficiency virus (HIV) infection. Ann N Y Acad Sci 1990; 587: 189-95.
32. Ullrich R, Schneider T, Heise W, Schmidt W, Averdunk R, Riecken EO, Zeitz M. Serum carotene deficiency in HIV-infected patients. Berlin Diarrhoea/Wasting Syndrome Study Group. AIDS 1994; 8: 661-5.
33. Skurnick JH, Bogden JD, Baker H, Kemp FW, Sheffet A, Quattrone G, Louria DB. Micronutrient profiles in HIV-1-infected heterosexual adults. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12: 75-83.
34. Baeten JM, McClelland RS, Wener MH, Bankson DD, Lavreys L, Mandaliya K, Bwayo JJ, Kreiss JK. Relationship between markers of HIV-1 disease progression and serum beta-carotene concentrations in Kenyan women. Int J STD AIDS 2007; 18: 202-6.
35. Stephensen CB, Marquis GS, Kruzich LA, Douglas SD, Aldrovandi GM, Wilson CM. Vitamin D status in adolescents and young adults with HIV infection. Am J Clin Nutr 2006; 83: 1135-41.
36. Van Den Bout-Van Den Beukel CJ, Fievez L, Michels M, Sweep FC, Hermus AR, Bosch ME, Burger DM, Bravenboer B, Koopmans PP, Van Der Ven AJ. Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses 2008; 24: 1375-82.
37. Rodriguez M, Daniels B, Gunawardene S, Robbins GK. High frequency of vitamin D deficiency in ambulatory HIV-positive patients. AIDS Res Hum Retroviruses 2009; 25: 9-14.
38. Mehta S, Hunter DJ, Mugusi FM, Spiegelman D, Manji KP, Giovannucci EL, Hertzmark E, Msamanga GI, Fawzi WW. Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal vitamin D status in Tanzania. J Infect Dis 2009; 200: 1022-30.
39. Baum MK, Shor-Posner G, Lu Y, Rosner B, Sauberlich HE, Fletcher MA, Szapocznik J, Eisdorfer C, Buring JE, Hennekens CH. Micronutrients and HIV-1 disease progression. AIDS 1995; 9: 1051-6.
40. Jordao Junior AA, Silveira S, Figueiredo JF, Vannucchi H. Urinary excretion and plasma vitamin E levels in patients with AIDS. Nutrition 1998; 14: 423-6.
41. Papathakis PC, Rollins NC, Chantry CJ, Bennish ML, Brown KH. Micronutrient status during lactation in HIV-infected and HIV-uninfected South African women during the first 6 mo after delivery. Am J Clin Nutr 2007; 85: 182-92.
42. Coodley G, Girard DE. Vitamins and minerals in HIV infection. J Gen Intern Med 1991; 6: 472-9.
43. Stephensen CB, Marquis GS, Jacob RA, Kruzich LA, Douglas SD, Wilson CM. Vitamins C and E in adolescents and young adults with HIV infection. Am J Clin Nutr 2006; 83: 870-9.
44. Srinivas A, Dias BF. Antioxidants in HIV positive children. Indian J Pediatr 2008; 75: 347-50.
45. Tang AM, Graham NM, Chandra RK, Saah AJ. Low serum vitamin B-12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression. J Nutr 1997; 127: 345-51.
46. Burkes RL, Cohen H, Krailo M, Sinow RM, Carmel R. Low serum cobalamin levels occur frequently in the acquired immune deficiency syndrome and related disorders. Eur J Haematol 1987; 38: 141-7.
47. 12, and HIV infection. Lancet 1990; 335: 1401-2.
48. 12 transport proteins in patients with HIV-1 infection and AIDS. Haematologica 1993; 78: 84-8.
49. 12 and transcobalamin levels in early HIV disease. Am J Hematol 1994; 47: 167-71.
50. 12 levels in patients infected with the human immunodeficiency virus. Am J Hematol 1995; 49: 318-22.
51. 12 levels in an outpatient HIV-infected population. Int J STD AIDS 2004; 15: 127-33.
52. Friis H, Gomo E, Koestel P, Ndhlovu P, Nyazema N, Krarup H, Michaelsen KF. HIV and other predictors of serum folate, serum ferritin, and hemoglobin in pregnancy: a cross-sectional study in Zimbabwe. Am J Clin Nutr 2001; 73: 1066-73.
53. 12 parameters in HIV-1 infected patients with anaemia in southern Brazil. Trop Doct 2009; 39: 83-5.
54. Koch J, Neal EA, Schlott MJ, Garcia-Shelton YL, Chan MF, Weaver KE, Cello JP. Zinc levels and infections in hospitalized patients with AIDS. Nutrition 1996; 12: 515-8.
55. Wellinghausen N, Kern WV, Jöchle W, Kern P. Zinc serum level in human immunodeficiency virus-infected patients in relation to immunological status. Biol Trace Elem Res 2000; 73: 139-49.
56. Totin D, Ndugwa C, Mmiro F, Perry RT, Jackson JB, Semba RD. Iron deficiency anemia is highly prevalent among human immunodeficiency virus-infected and uninfected infants in Uganda. J Nutr 2002; 132: 324-9.
57. Castaldo A, Tarallo L, Palomba E, Albano F, Russo S, Zuin G, Buffardi F, Guarino A. Iron deficiency and intestinal malabsorption in HIV disease. J Pediatr Gastroenterol Nutr 1996; 22: 359-63.
58. Ray A, Ndugwa C, Mmirot F, Ricks MO, Semba RD. Soluble transferrin receptor as an indicator of iron deficiency in HIV-infected infants. Ann Trop Paediatr 2007; 27: 11-6.
59. Semba RD, Shah N, Strathdee SA, Vlahov D. High prevalence of iron deficiency and anemia among female injection drug users with and without HIV infection. J Acquir Immune Defic Syndr 2002; 29: 142-4.
60. Dancheck B, Tang AM, Thomas AM, Smit E, Vlahov D, Semba RD. Injection drug use is an independent risk factor for iron deficiency and iron deficiency anemia among HIV-seropositive and HIV-seronegative women. J Acquir Immune Defic Syndr 2005; 40: 198-201.
61. Semba RD, Kumwenda N, Hoover DR, Taha TE, Mtimavalye L, Broadhead R, Eisinger W, Miotti PG, Chiphangwi JD. Assessment of iron status using plasma transferrin receptor in pregnant women with and without human immunodeficiency virus in Malawi. Eur J Clin Nutr 2000; 54: 872-7.
62. Semba RD, Taha TE, Kumwenda N, Mtimavalye L, Broadhead R, Miotti PG, Chiphangwi JD. Iron status and indicators of human immunodeficiency virus disease severity among pregnant women in Malawi. Clin Infect Dis 2001; 32: 1496-9.
63. Antelman G, Msamanga GI, Spiegelman D, Urassa EJ, Narh R, Hunter DJ, Fawzi WW. Nutritional factors and infectious disease contribute to anemia among pregnant women with human immunodeficiency virus in Tanzania. J Nutr 2000; 130: 1950-7.
64. Kupka R, Msamanga GI, Mugusi F, Petraro P, Hunter DJ, Fawzi WW. Iron status is an important cause of anemia in HIV-infected Tanzanian women but is not related to accelerated HIV disease progression. J Nutr 2007; 137: 2317-23.
65. Dworkin BM, Rosenthal WS, Wormser GP, Weiss L. Selenium deficiency in the acquired immunodeficiency syndrome. JPEN J Parenter Enteral Nutr 1986; 10: 405-7.
66. Mantero-Atienza E, Beach RS, Gavancho MC, Morgan R, Shor-Posner G, Fordyce-Baum MK. Selenium status of HIV-1 infected individuals. JPEN J Parenter Enteral Nutr 1991; 15: 693-4.
67. Semba RD, Miotti PG, Chiphangwi JD, Liomba G, Yang LP, Saah AJ, Dailabetta GA, Hoover DR. Infant mortality and maternal vitamin A deficiency during human immunodeficiency virus infection. Clin Infect Dis 1995; 21: 966-72.
68. Semba RD, Miotti P, Chiphangwi JD, Henderson R, Dallabetta G, Yang LP, Hoover D. Maternal vitamin A deficiency and child growth failure during human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retroviral 1997; 14: 219-22.
69. Chatterjee A, Bosch RJ, Hunter DJ, Manji K, Msamanga GI, Fawzi WW. Vitamin A and vitamin B-12 concentrations in relation to morbidity and mortality among children born to HIV-infected women. J Trop Pediatr 2010; 56: 27-35.
70. John GC, Nduati RW, Mbori-Ngacha D, Overbaugh J, Welch M, Richardson BA, Ndinya-Achola J, Bwayo J, Krieger J, Onyango F, Kreiss JK. Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis 1997; 175: 57-62.
71. Nduati RW, John GC, Richardson BA, Overbaugh J, Welch M, Ndinya-Achola J, Moses S, Holmes K, Onyango F, Kreiss JK. Human immunodeficiency virus type 1-infected cells in breast milk: association with immunosuppression and vitamin A deficiency. J Infect Dis 1995; 172: 1461-8.
72. Villamor E, Kapiga SH, Fawzi WW. Vitamin A serostatus and heterosexual transmission of HIV: case-control study in Tanzania and review of the evidence. Int J Vitam Nutr Res 2006; 76: 81-5.
73. MacDonald KS, Malonza I, Chen DK, Nagelkerke NJ, Nasio JM, Ndinya-Achola J, Bwayo JJ, Sitar DS, Aoki FY, Plummer FA. Vitamin A and risk of HIV-1 seroconversion among Kenyan men with genital ulcers. AIDS 2001; 15: 635-9.
74. Thurnham DI, Mburu AS, Mwaniki DL, Muniu EM, Alumasa F, de Wagt A. Using plasma acute-phase protein concentrations to interpret nutritional biomarkers in apparently healthy HIV-1-seropositive Kenyan adults. Br J Nutr 2008; 100: 174-82.
75. Mehendale SM, Shepherd ME, Brookmeyer RS, Semba RD, Divekar AD, Gangakhedkar RR, Joshi S, Risbud AR, Paranjape RS, Gadkari DA, Bollinger RC. Low carotenoid concentration and the risk of HIV seroconversion in Pune, India. J Acquir Immune Defic Syndr 2001; 26: 352-9.
76. Graham SM, Baeten JM, Richardson BA, Bankson DD, Lavreys L, Ndinya-Achola JO, Mandaliya K, Overbaugh J, McClelland RS. Higher pre-infection vitamin E levels are associated with higher mortality in HIV-1-infected Kenyan women: a prospective study. BMC Infect Dis 2007; 7: 63.
77. Tang AM, Graham NMH, Saah AJ. Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection. Am J Epidemiol 1996; 143: 1244-56.
78. Kanter AS, Spencer DC, Steinberg MH, Soltysik R, Yarnold PR, Graham NM. Supplemental vitamin B and progression to AIDS and death in black South African patients infected with HIV J Acquir Immune Defic Syndr 1999; 21: 252-3.
79. Graham NM, Sorensen D, Odaka N, Brookmeyer R, Chan D, Willett WC, Morris JS, Saah AJ. Relationship of serum copper and zinc levels to HIV-1 seropositivity and progression to AIDS. J Acquir Immune Defic Syndr 1991; 4: 976-80.
80. Cirelli A, Ciardi M, de Simone C, Sorice F, Giordano R, Ciaralli L, Costantini S. Serum selenium concentration and disease progress in patients with HIV infection. Clin Biochem 1991; 24: 211-4.
81. Kupka R, Msamanga GI, Spiegelman D, Morris S, Mugusi F, Hunter DJ, Fawzi WW. Selenium status is associated with accelerated HIV disease progression among HIV-1-infected pregnant women in Tanzania. J Nutr 2004; 134: 2556-60.
82. Baum MK, Shor-Posner G, Lai S, Zhang G, Lai H, Fletcher MA, Sauberlich H, Page JB. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retroviral 1997; 15: 370-4.
83. Campa A, Shor-Posner G, Indacochea F, Zhang G, Lai H, Asthana D, Scott GB, Baum MK. Mortality risk in selenium-deficient HIV-positive children. J Acquir Immune Defic Syndr Hum Retroviral 1999; 20: 508-13.
84. Kupka R, Msamanga GI, Spiegelman D, Rifai N, Hunter DJ, Fawzi WW. Selenium levels in relation to morbidity and mortality among children born to HIV-infected mothers. Eur J Clin Nutr 2005; 59: 1250-8.
85. Kupka R, Garland M, Msamanga G, Spiegelman D, Hunter D, Fawzi W. Selenium status, pregnancy outcomes, and mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr 2005; 39: 203-10.
86. Baeten JM, Mostad SB, Hughes MP, Overbaugh J, Bankson DD, Mandaliya K, Ndinya-Achola JO, Bwayo JJ, Kreiss JK. Selenium deficiency is associated with shedding of HIV-1-infected cells in the female genital tract. J Acquir Immune Defic Syndr 2001; 26: 360-4.
87. Shor-Posner G, Miguez MJ, Pineda LM, Rodriguez A, Ruiz P, Castillo G, Burbano X, Lecusay R, Baum M. Impact of selenium status on the pathogenesis of mycobacterial disease in HIV-1-infected drug users during the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 29: 169-73.
88. Chariot P, Dubreuil-Lemaire ML, Zhou JY, Lamia B, Dume L, Larcher B, Monnet I, Levy Y, Astier A, Gherardi R. Muscle involvement in human immunodeficiency virus-infected patients is associated with marked selenium deficiency. Muscle Nerve 1997; 20: 385-9.
89. Serwadda D, Mugerwa RD, Sewankambo NK, Lwegaba A, Carswell JW, Kirya GB, Bayley AC, Downing RG, Tedder RS, Clayden SA, Dalgleish AG. Slim disease: a new disease in Uganda and its association with HTLVIII infection. Lancet 1985; 2: 849-52.
90. Wheeler DA, Gibert CL, Launer CA, Muurahainen N, Elion RA, Abrams DI, Bartsch GE. Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beim Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retroviral 1998; 18: 80-5.
91. Tang AM, Forrester J, Spiegelman D, Knox TA, Tchetgen E, Gorbach SL. Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 31: 230-6.
92. Jerene D, Endale A, Hailu Y, Lindtjørn B. Predictors of early death in a cohort of Ethiopian patients treated with HAART. BMC Infect Dis 2006; 6: 136.
93. Malvy E, Thiebaut R, Marimoutou C, Dabis F. Weight loss and body mass index as predictors of HIV disease progression to AIDS in adults. Aquitaine cohort, France, 1985-1997. J Am Coll Nutr 2001; 20: 609-15
94. Mangili A, Murman DH, Zampini AM, Wanke CA. Nutrition and HIV infection: review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort. Clin Infect Dis 2006; 42: 836-42.
95. Severe P, Leger P, Charles M, Noel F, Bonhomme G, Bois G, George E, Kenel-Pierre S, Wright PF, Gulick R, Johnson WD Jr, Pape JW, Fitzgerald DW. Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med 2005; 353: 2325-34.
96. Paton NI, Sangeetha S, Earnest A, Bellamy R. The impact of malnutrition on survival and CD4 count response in HIV-infected patients starting antiretroviral therapy. HIV Med 2006; 7: 323-30.
97. van der Sande MA, Schim van der Loeff MF, Aveika AA, Sabally S, Togun T, Sarge-Njie R, Alabi AS, Jaye A, Corrah T, Whittle HC. Body mass index at time of HIV diagnosis: a strong and independent predictor of survival. J Acquir Immune Defic Syndr 2004; 37: 1288-94.
98. Wanke CA, Silva M, Knox TA, Forrester J, Speigelman D, Gorbach SL. Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clin Infect Dis 2000; 31: 803-5.
99. Tang AM, Jacobson DL, Spiegelman D, Knox TA, Wanke C. Increasing risk of 5% or greater unintentional weight loss in a cohort of HIV-infected patients, 1995 to 2003. J Acquir Immune Defic Syndr 2005; 40: 70-6.
100. Zachariah R, Fitzgerald M, Massaquoi M, Pasulani O, Arnould L, Makombe S, Harries AD. Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS 2006; 20: 2355-60.
101. Schwenk A, Beisenherz A, Romer K, Kremer G, Salzberger B, Elia M. Phase angle from bioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviral treatment. Am J Clin Nutr 2000; 72: 496-501.
102. Kotler DP, Tierney AR, Wang J, Pierson RNJ. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989; 50: 444-7.
103. Babameto G, Kotler DP. Malnutrition in HIV infection. Gastroenterol Clin North Am 1997; 26: 393-415.
104. Wanke C, Kotler D. The approach to diagnosis and treatment of HIV wasting. J Acquir Immune Defic Syndr 2004; 37: S284-8.
105. Saghayam S, Kumarasamy N, Cecelia AJ, Solomon S, Mayer K, Wanke C. Weight and body shape change in a treatment-naïve population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India. Clin Infect Dis 2007; 44: 295-300.
106. Grunfeld C, Pang M, Shimizu L, Shigenaga JK, Jensen P, Feingold KR. Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr 1992; 55: 455-60.
107. Grunfeld C. What causes wasting in AIDS? N Engl J Med 1995; 333: 123-4.
108. Macallan DC, Noble C, Baldwin C, Foskett M, McManus T, Griffin GE. Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection. Am J Clin Nutr 1993; 58: 417-26.
109. Macallan DC. Wasting in HIV infection and AIDS. J Nutr 1999; 129: 238S-42S.
110. Macallan DC. Nutrition and immune function in human immunodeficiency virus infection. Proc Nutr Soc 1999; 58: 743-8.
111. Macallan DC, Noble C, Baldwin C, Jebb SA, Prentice AM, Coward WA, Sawyer MB, McManus TJ, Griffin GE. Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med 1995; 333: 83-8.
112. Young J. HIV and medical nutrition therapy. J Am Diet Assoc 1997; 10: S161-7.
113. Grinspoon S, Mulligan K. Weight loss and wasting in patients infected with human immunodeficiency virus. Clin Infect Dis 2003; 36: S69-78.
114. Villamor E, Manji K, Fawzi WW. Human Immunodeficiency virus infection. In: Semba RD, Bloem MW, eds. Nutrition and health in developing countries, 2nd ed. Totowa, NJ, USA: Humana Press, 2008: 307-39.
115. Michaelsen KF, Hoppe C, Roos N, Kaestel P, Stougaard M, Lauritzen L, Mølgaard C, Girma T, Friis H. Choice of foods and ingredients for moderately malnourished children 6 months to 5 years of age. Food Nutr Bull 2009; 30: S344-405.
116. Coutsoudis A, Bobat RA, Coovadia HM, Kuhn L, Tsai WY, Stein ZA. The effects of vitamin A supplementation on the morbidity of children born to HIV-infected women. Am J Public Health 1995; 85: 1076-81.
117. Fawzi WW, Mbise RL, Hertzmark E, Fataki MR, Herrera MG, Ndossi G, Spiegelman D. A randomized trial of vitamin A supplements in relation to mortality among human immunodeficiency virus-infected and uninfected children in Tanzania. Pediatr Infect Dis J 1999; 18: 127-33.
118. Fawzi WW, Mbise R, Spiegelman D, Fataki M, Hertzmark E, Ndossi G. Vitamin A supplements and diarrheal and respiratory tract infections among children in Dar es Salaam, Tanzania. J Pediatr 2000; 137: 660-7.
119. Villamor E, Mbise R, Spiegelman D, Hertzmark E, Fataki M, Peterson KE, Ndossi G, Fawzi WW. Vitamin A supplements ameliorate the adverse effect of HIV-1, malaria, and diarrheal infections on child growth. Pediatrics 2002; 109: E6.
120. Hanekom WA, Yogev R, Heald LM, Edwards KM, Hussey GD, Chadwick EG. Effect of vitamin A therapy on serologic responses and viral load changes after influenza vaccination in children infected with the human immunodeficiency virus. J Pediatr 2000; 136: 550-2.
121. Semba RD, Ndugwa C, Perry RT, Clark TD, Jackson JB, Melikian G, Tielsch J, Mmiro F. Effect of periodic vitamin A supplementation on mortality and morbidity of human immunodeficiency virus-infected children in Uganda: a controlled clinical trial. Nutrition 2005; 21: 25-31.
122. Kumwenda N, Miotti PG, Taha TE, Broadhead R, Biggar RJ, Jackson JB, Melikian G, Semba RD. Antenatal vitamin A supplementation increases birth weight and decreases anemia among infants born to human immunodeficiency virus-infected women in Malawi. Clin Infect Dis 2002; 35: 618-24.
123. Humphrey JH, Iliff PJ, Marinda ET, Mutasa K, Moulton LH, Chidawanyika H, Ward BJ, Nathoo KJ, Malaba LC, Zijenah LS, Zvandasara P, Ntozini R, Mzengeza F, Mahomva AI, Ruff AJ, Mbizvo MT, Zunguza CD; ZVITAMBO Study Group. Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality. J Infect Dis 2006; 193: 860-71.
124. Humphrey JH, Hargrove JW, Malaba LC, Iliff PJ, Moulton LH, Mutasa K, Zvandasara P, Nathoo KJ, Mzengeza F, Chidawanyika H, Zijenah LS, Ward BJ; ZVITAMBO Study Group. HIV incidence among postpartum women in Zimbabwe: risk factors and the effect of vitamin A supplementation. AIDS 2006; 20: 1437-46.
125. Miller MF, Stoltzfus RJ, Iliff PJ, Malaba LC, Mbuya NV; Zimbabwe Vitamin A for Mothers and Babies Project (ZVITAMBO) Study Group, Humphrey JH. Effect of maternal and neonatal vitamin A supplementation and other postnatal factors on anemia in Zimbabwean infants: a prospective, randomized study. Am J Clin Nutr 2006; 84: 212-22.
126. Baeten, J.M. McClelland R.S. Overbaugh, J. Richardson, B.A. Emery, S. Lavreys, L. Mandaliya, K. Bankson, D.D. Ndinya-Achola JO, Bwayo JJ, Kreiss JK. Vitamin A supplementation and human immunodeficiency virus type 1 shedding in women: results of a randomized clinical trial. J Infect Dis 2002; 185: 1187-91.
127. Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and β carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029-35.
128. Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, Hartman AM, Palmgren J, Freedman LS, Haapakoski J, Barrett MJ, Pietinen P, Malila N, Tala E, Liippo K, Salomaa ER, Tangrea JA, Teppo L, Askin FB, Taskinen E, Erozan Y, Greenwald P, Huttunen JK. α-Tocopherol and β-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, BetaCarotene Cancer Prevention Study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996; 88: 1560-70.
129. Törnwall ME, Virtamo J, Korhonen PA, Virtanen MJ, Taylor PR, Albanes D, Huttunen JK. Effect of a-tocopherol and β-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study. Eur Heart J 2004; 25: 1171-8. (Pubitemid 38834075)
130. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S, Hammar S. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334: 1150-5. (Pubitemid 26137973)
131. Palozza P. Prooxidant actions of carotenoids in biologic systems. Nutr Rev 1998; 56: 257-65. (Pubitemid 28445801)
132. McGill CR, Green NR, Meadows MC, Gropper SS. Beta-carotene supplementation decreases leukocyte superoxide dismutase activity and serum glutathione peroxidase concentration in humans. J Nutr Biochem 2003;1 4: 656-62.
133. Siems W, Wiswedel I, Salerno C, Crifò C, Augustin W, Schild L, Langhans CD, Sommerburg O. β-Carotene breakdown products may impair mitochondrial functions -potential side effects of high-dose β-carotene supplementation. J Nutr Biochem 2005; 16: 385-97. (Pubitemid 40909818)
134. Coodley GO, Coodley MK, Lusk R, Green TR, Bakke AC, Wilson D, Wachenheim D, Sexton G, Salveson C. Beta-carotene in HIV infection: an extended evaluation. AIDS 1996; 10: 967-73. (Pubitemid 26252626)
135. Nimmagadda AP, Burri BJ, Neidlinger T, O'Brien WA, Goetz MB. Effect of oral beta-carotene supplementation on plasma human immunodeficiency virus (HIV) RNA levels and CD4+ cell counts in HIV-infected patients. Clin Infect Dis 1998; 27: 1311-3. (Pubitemid 29242489)
136. Coutsoudis A, Pillay K, Spooner E, Kuhn L, Coovadia HM. Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. South African Vitamin A Study Group. AIDS 1999; 13: 1517-24.
137. Fawzi WW, Msamanga GI, Hunter D, Renjifo B, Antelman G, Bang H, Manji K, Kapiga S, Mwakagile D, Essex M, Spiegelman D. Randomized trial of vitamin supplements in relation to transmission of HIV-I through breastfeeding and early child mortality. AIDS 2002; 16: 1935-44.
138. Fawzi W, Msamanga G, Antelman G, Xu C, Hertzmark E, Spiegelman D, Hunter D, Anderson D. Effect of prenatal vitamin supplementation on lower-genital levels of HIV type 1 and interleukin type 1 beta at 36 weeks of gestation. Clin Infect Dis 2004; 38: 716-22. (Pubitemid 38333869)
139. Austin J, Singhal N, Voigt R, Smaill F, Gill MJ, Walmsley S, Salit I, Gilmour J, Schlech WF 3rd, Choudhri S, Rachlis A, Cohen J, Trottier S, Toma E, Phillips P, Ford PM, Woods R, Singer J, Zarowny DP, Cameron DW; CTN 091/CRIT Cartenoids Study Group. A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndrome. Eur J Clin Nutr 2006; 60: 1266-76.
140. Spada C, Treitinger A, Reis M, Masokawa IY, Verdi JC, Luiz MC, Silveira MV, Oliveira OV, Michelon CM, Avila-Júnior S, Gil DO, Ostrowsky S. An evaluation of antiretroviral therapy associated with alpha-tocopherol supplementation in HIV-infected patients. Clin Chem Lab Med 2002; 40: 456-9. (Pubitemid 34693084)
141. de Souza Júnior O, Treitinger A, Baggio GL, Michelon C, Verdi JC, Cunha J, Ferreira SI, Spada C. Alphatocopherol as an antiretroviral therapy supplement for HIV-1-infected patients for increased lymphocyte viability. Clin Chem Lab Med 2005; 3: 376-82. (Pubitemid 41460642)
142. Allard JP, Aghdassi E, Chau J, Tam C, Kovacs CM, Salit IE, Walmsley SL. Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects. AIDS 1998; 12: 1653-9. (Pubitemid 28418336)
143. Jaruga P, Jaruga B, Gackowski D, Olczak A, Halota W, Pawlowska M, Olinski R. Supplementation with antioxidant vitamins prevents oxidative modification of DNA in lymphocytes of HIV-infected patients. Free Radie Biol Med 2002; 32: 414-20. (Pubitemid 34178351)
144. McComsey G, Southwell H, Gripshover B, Salata R, Valdez H. Effect of antioxidants on glucose metabolism and plasma lipids in HIV-infected subjects with lipoatrophy. J Acquir Immune Defic Syndr 2004; 33: 605-7. (Pubitemid 36975848)
145. Delmas-Beauvieux MC, Peuchant E, Couchouron A, Constans J, Sergeant C, Simonoff M, Pellegrin JL, Leng B, Conri C, Clerc M. The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or beta-carotene. Am J Clin Nutr 1996; 64: 101-7. (Pubitemid 26241963)
146. Look MP, Rockstroh JK, Rao GS, Barton S, Lemoch H, Kaiser R, Kupfer B, Sudhop T, Spengler U, Sauerbruch T. Sodium selenite and N-acetylcysteine in antiretroviralnaive HIV-1-infected patients: a randomized, controlled pilot study. Eur J Clin Invest 1998; 28: 389-97. (Pubitemid 28261223)
147. Burbano X, Miguez-Burbano MJ, McCollister K, Zhang G, Rodriguez A, Ruiz P, Lecusay R, Shor-Posner G. Impact of a selenium chemoprevention clinical trial on hospital admissions of HIV-infected participants. HIV Clin Trials 2002; 3: 483-91. (Pubitemid 36013557)
148. Hurwitz BE, Klaus JR, Llabre MM, Gonzalez A, Lawrence PJ, Maher KJ, Greeson JM, Baum MK, ShorPosner G, Skyler JS, Schneiderman N. Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial. Arch Intern Med 2007; 167: 148-54. (Pubitemid 46148061)
149. Ross DA, Cousens S, Wedner SH, Sismanidis C. Does selenium supplementation slow progression of HIV? Potentially misleading presentation of the results of a trial. Arch Intern Med 2007; 167: 1555-6. (Pubitemid 47124195)
150. Passaretti C, Gupta A. Selenium and HIV-1: hype or hope? Arch Intern Med 2007; 167: 2530-1.
151. Dillon DM, Stapleton JT. Selenium effects on HIV RNA and CD4 cell counts. Arch Intern Med 2007; 67: 1556-7.
152. Kupka R, Mugusi F, Aboud S, Msamanga GI, Finkelstein JL, Spiegelman D, Fawzi WW. Randomized, doubleblind, placebo-controlled trial of selenium supplements among HIV-infected pregnant women in Tanzania: effects on maternal and child outcomes. Am J Clin Nutr 2008; 87: 1802-8. (Pubitemid 351872645)
153. Kupka R, Mugusi F, Aboud S, Hertzmark E, Spiegelman D, Fawzi WW. Effect of selenium supplements on hemoglobin concentration and morbidity among HIV-1-infected Tanzanian women. Clin Infect Dis 2009; 48: 1475-8.
154. Fawzi WW, Villamor E, Msamanga GI, Antelman G, Aboud S, Urassa W, Hunter D. A trial of zinc supplements in relation to pregnancy outcomes, hematologic indicators, and T-cell counts among HIV-1 infected women in Tanzania. Am J Clin Nutr 2005; 81: 161-7. (Pubitemid 43073390)
155. Villamor E, Aboud S, Koulinska IN, Kupka R, Urassa W, Chaplin B, Msamanga G, Fawzi WW. Zinc supplementation to HIV-1-infected pregnant women: effects on maternal anthropometry, viral load, and early motherto-child transmission. Eur J Clin Nutr 2006; 60: 862-9. (Pubitemid 43997698)
156. Cárcamo C, Hooton T, Weiss NS, Gilman R, Wener MH, Chavez V, Meneses R, Echevarria J, Vidal M, Holmes KK. Randomized controlled trial of zinc supplementation for persistent diarrhea in adults with HIV-1 infection. J Acquir Immune Defic Syndr 2006; 43: 197-201. (Pubitemid 44454814)
157. Deloria-Knoll M, Steinhoff M, Semba RD, Nelson K, Vlahov D, Meinert CL. Effect of zinc and vitamin A supplementation on antibody responses to a pneumococcal conjugate vaccine in HIV-positive injection drug users: a randomized trial. Vaccine 2006; 24: 1670-9. (Pubitemid 43238244)
158. Clark TD, Semba RD. Iron supplementation during human immunodeficiency virus infection: a doubleedged sword? Med Hypotheses 2001; 57: 476-9.
159. Olsen A, Mwaniki D, Krarup H, Friis H. Low-dose iron supplementation does not increase HIV-1 load. J Acquir Immune Defic Syndr 2004; 36: 637-8. (Pubitemid 38544514)
160. Semba RD, Ricketts EP, Mehta S, Netski D, Thomas D, Kirk G, Wu AW, Vlahov D. Effect of micronutrients and iron supplementation on hemoglobin, iron status, and plasma hepatitis C and HIV RNA levels in female injection drug users: a controlled clinical trial. J Acquir Immune Defic Syndr 2007; 45: 298-303. (Pubitemid 47012376)
161. Fawzi WW, Msamanga GI, Spiegelman D, Urassa EJ, McGrath N, Mwakagile D, Antelman G, Mbise R, Herrera G, Kapiga S, Willett W, Hunter DJ. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet 1998; 351: 1477-82. (Pubitemid 28227039)
162. Villamor E, Msamanga G, Spiegelman D, Antelman G, Peterson KE, Hunter DJ, Fawzi WW. Effect of multivitamin and vitamin A supplements on weight gain during pregnancy among HIV-1-infected women. Am J Clin Nutr 2002; 76: 1082-90. (Pubitemid 35244681)
163. Fawzi WW, Msamanga G, Hunter D, Urassa E, Renjifo B, Mwakagile D, Hertzmark E, Coley J, Garland M, Kapiga S, Antelman G, Essex M, Spiegelman D. Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania. J Acquir Immune Defic Syndr 2000; 23: 246-54.
164. Fawzi WW, Msamanga GI, Wei R, Spiegelman D, Antelman G, Villamor E, Manji K, Hunter D. Effect of providing vitamin supplements to human immunodeficiency virus-infected, lactating mothers on the child's morbidity and CD4+ cell counts. Clin Infect Dis 2003; 36: 1053-62. (Pubitemid 36513292)
165. Villamor E, Saathoff E, Bosch RJ, Hertzmark E, Baylin A, Manji K, Msamanga G, Hunter DJ, Fawzi WW. Vitamin supplementation of HIV-infected women improves postnatal child growth. Am J Clin Nutr 2005; 81: 880-8. (Pubitemid 41724998)
166. Fawzi WW, Msamanga GI, Kupka R, Spiegelman D, Villamor E, Mugusi F, Wei R, Hunter D. Multivitamin supplementation improves hematologic status in HIVinfected women and their children in Tanzania. Am J Clin Nutr 2007; 85: 1335-43. (Pubitemid 46740477)
167. Fawzi WW, Msamanga GI, Spiegelman D, Wei R, Kapiga S, Villamor E, Mwakagile D, Mugusi F, Hertzmark E, Essex M, Hunter DJ. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med 2004; 351: 23-32. (Pubitemid 38857244)
168. Villamor E, Saathoff E, Manji K, Msamanga G, Hunter DJ, Fawzi WW. Vitamin supplements, socioeconomic status, and morbidity events as predictors of wasting in HIV-infected women from Tanzania. Am J Clin Nutr 2005; 82: 857-65. (Pubitemid 43779701)
169. Kelly P, Musonda R, Kafwembe E, Kaetano L, Keane E, Farthing M. Micronutrient supplementation in the AIDS diarrhoea-wasting syndrome in Zambia: a randomized controlled trial. AIDS 1999; 13: 495-500.
170. Kelly P, Katubulushi M, Todd J, Banda R, Yambayamba V, Fwoloshi M, Zulu I, Kafwembe E, Yavwa F, Sanderson IR, Tomkins A. Micronutrient supplementation has limited effects on intestinal infectious disease and mortality in a Zambian population of mixed HIV status: a cluster randomized trial. Am J Clin Nutr 2008; 88: 1010-7.
171. Jiamton S, Pepin J, Suttent R, Filteau S, Mahakkanukrauh B, Hanshaoworakul W, Chaisilwattana P, Suthipinittharm P, Sherry P, Jaffar S. A randomized trial of the impact of multiple micronutrient supplementation on mortality among HIV-infected individuals living in Bangkok. AIDS 2003; 17: 2461-9. (Pubitemid 38393318)
172. McClelland RS, Baeten JM, Overbaugh J, Richardson BA, Mandaliya K, Emery S, Lavreys L, Ndinya-Achola JO, Bankson DD, Bwayo JJ, Kreiss JK. Micronutrient supplementation increases genital tract shedding of HIV-1 in women: results of a randomized trial. J Acquir Immune Defic Syndr 2004; 37: 1657-63. (Pubitemid 39658209)
173. Kaiser JD, Campa AM, Ondercin JP, Leoung GS, Pless RF, Baum MK. Micronutrient supplementation increases CD4 count in HIV-infected individuals on highly active antiretroviral therapy: a prospective, double-blinded, placebo-controlled trial. J Acquir Immune Defic Syndr 2006; 42: 523-8.
174. Batterham M, Gold J, Naidoo D, Lux O, Sadler S, Bridle S, Ewing M, Oliver C. A preliminary open label dose comparison using an antioxidant regiment to determine the effect on viral load and oxidative stress in men with HIV/AIDS. Eur J Clin Nutr 2001; 55: 107-14. (Pubitemid 32156890)
175. Berneis K, Battegay M, Bassetti S, Nuesch R, Leisibach A, Bilz S, Keller U. Nutritional supplements combined with dietary counseling diminish whole body protein catabolism in HIV-infected patients. Eur J Clin Invest 2000; 30: 87-94. (Pubitemid 30073889)
176. Paton NI, Chua Y-K, Earnest A, Chee CBE. Randomized controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting. Am J Clin Nutr 2004; 80: 460-5.
177. Johns KKJ, Beddall MJ, Corrin RC. Anabolic steroids for the treatment of weight loss in HIV-infected individuals. Cochrane Database Syst Rev 2005; 4: CD005483.
178. Gelato MM, McNurlan M, Freedland E. Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment. Clin Ther 2007; 29: 2269-88. (Pubitemid 350298124)
179. Mda S, van Raaij JMA, MacIntyre UE, de Villiers FPR, Kok FJ. Improved appetite after multi-micronutrient supplementation for six months in HIV-infected South African children. Appetite 2010; 54: 150-5.
180. Shikuma CM, Zacklin R, Sattler F, Mildvan D, Nyangweso P, Alston B, Evans S, Mulligan K. Changes in weight and lean body mass during highly active antiretroviral therapy. Clin Infect Dis 2004; 39: 1223-30. (Pubitemid 40169323)
181. Madec Y, Szumilin E, Genevier C, Ferradini L, Balkan S, Pujades M, Fontanet A. Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries. AIDS 2009; 23: 853-61.
182. Castleman T, Seumo-Fosso E, Cogill B. Food and nutrition implications of antiretroviral therapy in resource limited settings. Food and Nutrition Technical Assistance (FANTA) Technical Note No 7. Washington, DC: FANTA, 2004.
183. Ivers LC, Cullen KA, Freedberg KA, Block S, Coates J, Webb P. HIV/AIDS, undernutrition, and food insecurity. Clin Infect Dis 2009; 49: 1096-102.
184. Weiser SD, Tuller DM, Frongillo EA, Senkungu J, Mukiibi N, Bangsberg DR. Food insecurity as a barrier to sustained antiretroviral therapy adherence in Uganda. PLoS ONE 2010; 5(4):e10340. Available at: http://www. ncbi.nlm.nih.gov/pmc/articles/PMC2860981/pdf/ pone.0010340.pdf. Accessed 22 September 2010.
185. Weiser SD, Frongillo EA, Ragland K, Hogg RS, Riley ED, Bangsberg DR. Food insecurity is associated with incomplete HIV RNA suppression among homeless and marginaily housed HIV-infected individuals in San Francisco. J Gen Intern Med 2009; 24: 14-20.
186. Weiser SD, Fernandes KA, Brandson EK, Lima VD, Anema A, Bangsberg DR, Montaner JS, Hogg RS. The association between food insecurity and mortality among HIV-infected individuals on HAART. J Acquir Immune Defic Syndr 2009; 3: 342-9.
187. World Health Organization. Essential prevention and care interventions for adults and adolescents living with HIV in resource-limited settings. Geneva: WHO, 2008.
188. Piwoz E. Nutrition and HIV/AIDS: evidence, gaps, and priority actions. Washington, DC: US Agency for International Development, 2004.
189. Greenaway K. GAIN Working Paper Series. No 2: food by prescription: a landscape paper. Geneva, GAIN, UNAIDS, WFP. 2009. Available at: http://www.gainhealth.org/sites/default/files/Working%20Paper%202. pdf. Accessed 19 August 2010.
190. World Health Organization. Nutrient requirements for people living with HIV/AIDS. Report of a technical consultation. Geneva: WHO, 2003.
191. World Health Organization. Management of severe malnutrition. A manual for physicians and other senior health workers. Geneva: WHO, 1999.
192. World Health Organization. Department of Nutrition for Health and Development. Executive summary of a scientific review. Consultation on nutrition and HIV/ AIDS in Africa: evidence, lessons and recommendations for action. Durban, South Africa 10-13 April 2005. Available from: http://www.who.int/ entity/nutrition/ topics/Executive%20Summary%20WHO.pdf. Accessed 14 September 2010.
193. Food and Nutrition Technical Assistance. HIV/AIDS: a guide for nutritional care and support, 2nd ed. Washington, DC: FANTA, Academy for Educational Development, 2004.
194. Department of Health. Directorate: Nutrition. National guidelines on nutrition for people living with HIV, AIDS, TB and other chronic debilitating conditions. Pretoria, South Africa: Department of Health, 2006: 1-77.
195. Hsu JW-C, Pencharz PB, Macallan D, Tomkins A. Macronutrients and HIV/AIDS: a review of current evidence. Consultation on Nutrition and HIV/AIDS in Africa: evidence, lessons and recommendations for action. Durban, South Africa, 10-13 April 2005. Geneva, World Health Organization. Available from http://www.who.int/entity/nutrition/topics/Paper%20 Number%201%20- %20Macronutrients.pdf. Accessed 14 September 2010.
196. Ndekha M, van Oosterhout JJ, Zijlstra E, Manary M, Saloojee H, Manary M. Supplementary feeding with either ready-to-use fortified spread or corn-soy blend in wasted adults starting antiretroviral therapy in Malawi: randomized investigator blinded, controlled trial. BMJ 2009; 338: b1867.
197. Bahwere P, Sadler K, Collins S. Acceptability and effectiveness of chickpea sesame-based ready-to-use therapeutic food in malnourished HIV-positive adults. Patient Prefer Adherence 2009; 3: 67-75.
198. Dibari F. A qualitative investigation of Plumpynut consumption and access in adults enrolled in an MoH/ MSF HIV programme in Kenya. 2008. Available at: http://www.validinternational.org/demo/reports// HIV/080515%20MSF%20- %20abstract.pdf. Accessed 19 August 2010.
199. Golden MH. Proposed recommended nutrient densities for moderately malnourished children. Food Nutr Bull 2009; 30: S267-343.
200. Mahlungulu SSN, Grobler L, Visser MME, Volmink J. Nutritional interventions for reducing morbidity and mortality in people with HIV. Cochrane Database Syst Rev 2007; 3: CD004536. (Pubitemid 351805579)
201. Academy of Sciences of South Africa (ASSAf). HIV/ AIDS, TB and nutrition. Scientific inquiry into the nutritional influences on human immunity with special reference to HIV infection and active TB in South Africa. 2007. ASSAf, Pretoria, South Africa. Available at: www.assaf.org.za. Accessed 19 August 2010.
202. Karsegard VL, Raguso CA, Genton L, Hirschel B, Pichard C. L-Ornithine alpha-ketoglutarate in HIV infection: effects of muscle, gastrointestinal, and immune functions. Nutrition 2004; 20: 515-20. (Pubitemid 38692493)
203. Shabert JK, Winslow C, Lacey JM, Wilmore DW Glutamine-antioxidant supplementation increases body cell mass in AIDS patients with weight loss: a randomized, double-blind controlled trial. Nutrition 1999; 15: 860-4. (Pubitemid 29518470)
204. Koethe JR, Chi BH, Megazinni KM, Heimburger DC, Stringer JSA. Macronutrient supplementation for malnourished HIV-infected adults: a review of the evidence in resource-adequate and resource-constrained settings. Clin Infect Dis 2009; 49: 787-98.
205. Cantrell RA, Sinkala M, Megazinni K, Lawson-Marriott S, Washington S, Chi BH, Tambatamba-Chapula B, Levy J, Stringer EM, Mulenga L, Stringer JS. A pilot study of food supplementation to improve adherence to antiretroviral therapy among food-insecure adults in Lusaka, Zambia. J Acquir Immune Defic Syndr 2008; 49: 190-5.
206. de Pee S, Bloem MW. Current and potential role of specially formulated foods and food supplements for preventing malnutrition among 6-23 months old and treating moderate malnutrition among 6-59 months old children. Background paper prepared for WHO UNICEF WFP UNHCR informal consultation on the management of moderate malnutrition in under-5 children. Food Nutr Bull 2009; 30: S434-63.
207. Ndekha M, van Oosterhout JJG, Saloojee H, Pettifor J, Manary M. Nutritional status of Malawian adults on antiretroviral therapy 1 year after supplementary feeding in the first 3 months of therapy. Trop Med Int Health 2009; 14: 1-5.
208. van Oosterhout JJ, Ndekha MJ, Moore E, Kumwenda JJ, Zijlstra EE, Manary M. The benefit of supplementary feeding for wasted Malawian adults initiating ART. AIDS Care 2010; 22: 737-42.
209. Bowie C, Kalilani L, Marsh R, Misiri H, Cleary P, Bowie C. An assessment of food supplementation to chronically sick patients receiving home based care in Bangwe, Malawi: a descriptive study. Nutr J 2005;12. doi:10.1186/1475-2891-4- 12. Available at: http://www.nutritionj. com/content/4/1/12. Accessed 22 September 2010.
210. Matilsky DK, Maleta K, Castleman T, Manary MJ. Supplementary feeding with fortified spreads results in higher recovery rates than with a corn/soy blend in moderately wasted children. J Nutr 2009; 139: 773-8.
211. Piwoz EG, Preble EA. HIV/AIDS and nutrition: a review of the literature and recommendations for nutritional care and support in Sub-Saharan Africa. Washington, DC: US Agency for International Development, 2000.
212. Rollins N. Food supplements and HIV. More is not necessarily better. BMJ 2009; 338: 1282-3.